Company Overview and News
One of Wednesday's biggest losers so far is IBM (IBM), after the company reported third quarter results Tuesday afternoon. While the report showed another adjusted bottom line beat, it was the top line that surprised in a big way, and not to the good side. As the revenue picture continues to be quite murky, perhaps it is time for a change in leadership.
AAPL DIA CSCO MSFT INTC CSCOI
3h investorplace - 1
It’s important not to overreact to the recent declines in Nvidia (NASDAQ:NVDA) stock. Long-term, I still believe Nvidia stock is a buy. Short-term, it has been a different story. Nvidia stock has fallen 18% in just the last eight trading sessions before today.
LRCX SOXX SQ SHOP TXN MU AMAT AMD NVDA QCOM INTC
Softbank Group Chief Operating Officer Marcelo Claure said it is "business at usual" at the companies backed by its nearly US$100 billion Vision Fund despite a tense situation with Saudi Arabia, which provided nearly half of the fund's capital.
AAPL 9984 SFTBF INTC QCOM SFTBY
Last week, just days after flirting with the 27,000 threshold and setting new record highs, the Dow Jones Industrial Average plunged on worries over the impact rising long-term interest rates would have on the economy amid the Federal Reserve’s ongoing tightening cycle. This week, after the harrowing selloff, U.S. equities found respite thanks to these Dow Jones stocks.
DB CVX VZ KO BA INTC MCD DIS
Micron Technology (NASDAQ:MU), which provides semiconductor systems, has had a difficult time since June. So far in October, it has suffered further along with other technology stocks. While high volatility in the broader technology market is likely to continue for several more weeks, there are two mildly bearish plays in MU stock that I want to share with you, as each play could lead to impressive profits.
MU AMD NVDA INTC
2018-10-15 investorplace - 1
Last week’s market collapse made headlines throughout the world. Even my professional associates who aren’t necessarily investment-savvy asked for my thoughts and guidance. After years of robust returns, the thought of a widespread correction is jarring. Nevertheless, you still want to keep your wits about you, as this is an ideal time to consider which stocks to buy.
AMZN ABX T PX JNJ XOM VZ INTC VZA ABX
Intel (INTC - Free Report) closed the most recent trading day at $44.53, moving -0.78% from the previous trading session. This change lagged the S&P 500's 0.59% loss on the day. At the same time, the Dow lost 0.35%, and the tech-heavy Nasdaq lost 0.88%.
LMT VBTX WSFS INTC WSFSL
2018-10-15 seekingalpha - 1
Despite the recent correction from its highs, mostly thanks to the market in a panic over rising interest rates, chipmaker Advanced Micro Devices (AMD) is still one of the year's biggest winners. As the company's turnaround has continued and it looks to steal share from giant Intel (INTC) in the server space, investors have sent AMD shares to multi-year highs. Recently, we've seen short sellers flee their positions in a meaningful way.
2018-10-15 zacks - 1
NVIDIA Corporation’s (NVDA - Free Report) efforts in artificial intelligence (AI) and machine learning in various fields are gathering momentum, thanks to its initiatives and adoption of its technologies by key companies. The past week has been quite eventful for NVIDIA. Swedish automaker Volvo Cars chose NVIDIA’s DRIVE AGX Xavier platform, an advanced car computer, to be incorporated in its next-generation automated cars.
AMD NVDA INTC ORCL
SEOUL, Oct. 14 (Yonhap) -- The semiconductor business of Samsung Electronics Co. and SK hynix Inc. made up 40.2 percent of all operating profit generated by South Korea's top 100 companies this year, industry data showed Sunday.
BC94 SMSN INTC QCOM SMSD
2018-10-13 seekingalpha - 3
Projections of short-term oversupply of DRAM and NAND memory chips are impacting memory companies like Samsung Electronics, Micron Technology, and SK Hynix.
LRCX SSNLF HXSCF MU AMAT AAPL BC94 SMSN INTC HXSCL SMSD
Micron Technology (MU - Free Report) , recently announced that it will spend $100 million in various artificial intelligence (AI) companies, especially hardware and software startups working on AI. Micron Foundation, the non-profit arm of Micron Technology, also announced that it will support universities and non-profit organizations in their research on AI) with a grant of $1 million. These investments by Micron follow investments of similar magnitude which have been made by magnates like Intel (INTC - Free Report) and NVIDIA Corp.
MU VSH NVDA INTC
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to INTC / Intel Corp. on message board site Silicon Investor.
as of ET